Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Lexicon Pharmaceuticals Company Profile (NASDAQ:LXRX)

Consensus Ratings for Lexicon Pharmaceuticals (NASDAQ:LXRX) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $7.67 (7.38% upside)

Analysts' Ratings History for Lexicon Pharmaceuticals (NASDAQ:LXRX)
Show:
DateFirmActionRatingPrice TargetActions
5/21/2015WedbushReiterated RatingOutperform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015ZacksReiterated RatingHold -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015WedbushReiterated RatingOutperform$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Needham & Company LLCReiterated RatingBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2015WedbushReiterated RatingOutperform$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2015WedbushReiterated RatingOutperform$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015Stifel NicolausLower Price TargetBuy$3.50 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014Stifel NicolausReiterated RatingBuy$4.00 -> $3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014GabelliDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/6/2013Bank of AmericaInitiated CoverageUnderperform$1.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/11/2013GabelliReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/11/2013Morgan StanleyDowngradeEqual Weight -> Underweight$2.00 -> $1.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2013Jefferies GroupInitiated CoverageBuy$3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/22/2013 forward)